Stay updated on Crenezumab in PSEN1 E280A Mutation Clinical Trial
Sign up to get notified when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.

Latest updates to the Crenezumab in PSEN1 E280A Mutation Clinical Trial page
- Check5 days agoChange DetectedThe site revision identifier changes from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedA site-wide notice announces FAQs about the NIH transition from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check19 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check46 days agoChange Detected403 Forbidden page now replaces the study record content for NCT01998841. Access to the trial details and related information is blocked on this page.SummaryDifference20%

- Check67 days agoChange DetectedRevision changed from v3.6.5 to v3.6.6, indicating an updated page version. This is a metadata update and does not modify the study details.SummaryDifference0.1%

Stay in the know with updates to Crenezumab in PSEN1 E280A Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.